Loading clinical trials...
Loading clinical trials...
An Open-Label, Single-Dose Study to Evaluate the Pharmacokinetics and Safety of BMS- 986177 in Participants With Normal Renal Function and Participants With Moderate and Severe Renal Impairment
Conditions
Interventions
BMS-986177
Locations
3
United States
Clinical Pharmacology Of Miami Inc.
Miami, Florida, United States
Clinical Pharmacology of Miami LLC
Miami, Florida, United States
Orlando Clinical Research Center
Orlando, Florida, United States
Start Date
July 13, 2017
Primary Completion Date
March 4, 2018
Completion Date
March 4, 2018
Last Updated
June 10, 2022
NCT07410117
NCT03830320
NCT07102160
NCT06658197
NCT05628948
NCT05967741
Lead Sponsor
Bristol-Myers Squibb
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions